GlassScriptPhysician profile
Amanda Jamieson
NPI 1063966406
$2,504.87
in general payments reported to CMS, 2019-2025
16 companies · $508 in 2025
The $508 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $286 · 2022: $389 · 2023: $404 · 2024: $918 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,604 · Travel and Lodging: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,604.17 |
| Travel and Lodging | $225.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $996.90 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $633.58 | 2021-2025 | Proclaim, Octrode |
| Scilex Pharmaceuticals INC. | $255.20 | 2021-2024 | Ztlido |
| Si-Bone, INC. | $107.84 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.81 | 2025 | Relistor |
| Medtronic, INC. | $68.75 | 2024-2025 | Intellis Adaptivestim |
| Ibsa Pharma INC. | $68.34 | 2021-2024 | Tirosint, Licart |
| Nevro Corp. | $61.98 | 2021-2024 | Senza |
| Appliedvr INC | $49.48 | 2025 | Relievrx |
| International Rehabilitative Sciences, INC | $38.69 | 2025 | Rs-4i Plus With Intersperse |
| Biotronik Nro, INC. | $38.68 | 2025 | Prospera |
| Redhill Biopharma INC. | $33.35 | 2021 | |
| Allergan, INC. | $23.70 | 2021 | |
| Abbvie INC. | $22.09 | 2022 | |
| Depuy Synthes Sales INC. | $20.40 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $14.08 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Jamieson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.